Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Profusa, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
PFSA
Nasdaq
3840
profusa.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Profusa, Inc.
Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3
- Nov 12th, 2026 5:30 am
Profusa Receives ISO 13485:2016 Certificate from GMED
- Oct 15th, 2026 4:30 am
Profusa ISO 13485 Certification Decision Advances Lumee Oxygen Platform Toward CE Mark
- Sep 24th, 2026 9:01 am
Profusa, Inc. Receives Nasdaq Compliance Determination
- Sep 15th, 2026 4:00 am
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
- Aug 31st, 2026 6:50 am
Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens
- Aug 20th, 2026 8:49 am
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
- Aug 20th, 2026 6:30 am
Profusa Announces 1-for-4 Reverse Stock Split
- Aug 13th, 2026 5:00 am
Profusa vies for potential G3 Vision Labs acquisition
- Aug 3rd, 2026 5:17 am
Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
- Jul 31st, 2026 3:15 pm
Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes
- Jul 27th, 2026 8:38 am
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
- Jul 27th, 2026 4:00 am
This Biotech Stock Crashed 28% Today After Announcing Second Reverse Share Split This Year
- Jul 2nd, 2026 10:48 am
Profusa Announces 1-for-25 Reverse Stock Split
- Jul 2nd, 2026 9:00 am
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
- Jun 24th, 2026 6:00 am
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for LumeeĀ® Oxygen Platform
- Jun 12th, 2026 6:00 am
Profusa Issues Letter to Shareholders Encouraging Shareholders to Vote FOR All Proposals at June 23, 2026 Annual Meeting
- Jun 10th, 2026 6:00 am
Profusa Announces Listing Transfer to The Nasdaq Capital Market
- May 15th, 2026 5:30 am
2 Reasons Quantum Cyber Has More Than Doubled Today
- May 14th, 2026 2:36 pm
Scroll